EDUCATION IN HEART

Cardiomyopathy

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

William J McKenna, Elijah R Behr

Correspondence to:
Correspondence to:
William J McKenna, MD, Department of Cardiological Sciences, St George's Hospital Medical School, Cranmer Road, London SW17 0RE, UK;
wmckenna@sghms.ac.uk

Keywords: hypertrophic cardiomyopathy; sudden death; risk stratification

Abbreviations: AF, atrial fibrillation; ASH, asymmetric septal hypertrophy; AV, atrioventricular; HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter-defibrillator; LVOT, left ventricular outflow tract; MyBPC, myosin binding protein C; NSVT, non-sustained ventricular tachycardia; SAM, systolic anterior motion of the mitral valve; SVT, supraventricular tachycardia; VF, ventricular fibrillation; VT, ventricular tachycardia; WPW, Wolff-Parkinson-White

Hypertrophic cardiomyopathy (HCM) is an inherited cardiac muscle disorder disease that affects sarcomeric proteins, resulting in small vessel disease, myocyte and myofibrillar disorganisation, and fibrosis with or without myocardial hypertrophy. These features may result in significant cardiac symptoms and are a potential substrate for arrhythmias. Before the identification of disease causing genes the World Health Organization defined HCM as the presence of left or biventricular hypertrophy in the absence of any cardiac or systemic cause.^w1 When these criteria are applied to a western population the estimated prevalence of HCM is approximately 1 in 500.^{1 w2} Morphological evidence of left ventricular hypertrophy, however, may be absent in up to 20% of gene carriers.^w3 Adults are often asymptomatic but their estimated mortality rate may nonetheless be as high as 1–2% per annum.^{2 w4} This article will present the natural history of HCM and relate it to the need for medical intervention to alleviate . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

WEB TOP 10
Heart 2002 87: 471. [Extract] [Full Text] [PDF]

WEB TOP TEN
Heart 2002 87: 345. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Maron, B. J., Maron, M. S., Wigle, E. D., Braunwald, E. (2009). The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.. J Am Coll Cardiol 54: 191-200 [Abstract] [Full Text]  
• Eckardt, L., Breithardt, G&#x.;n., Hohnloser, S. (2009). CHAPTER 30 Ventricular Tachycardia and Sudden Cardiac Death. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Melacini, P, Maron, B J, Bobbo, F, Basso, C, Tokajuk, B, Zucchetto, M, Thiene, G, Iliceto, S (2007). Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 93: 708-710 [Abstract] [Full Text]  
• Behr, E R, Casey, A, Sheppard, M, Wright, M, Bowker, T J, Davies, M J, McKenna, W J, Wood, D A (2007). Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death. Heart 93: 601-605 [Abstract] [Full Text]  
• Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]  
• Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]  
• Pedrote, A., Morales, F. J., Garcia-Riesco, L., Errazquin, F. (2006). Documented exercise-induced cardiac arrest in a paediatric patient with hypertrophic cardiomyopathy. Europace 8: 430-433 [Abstract] [Full Text]  
• McNally, E. M. (2006). Hypertrophic Cardiomyopathy: Exercise and Eat Right. Circ. Res. 98: 443-445 [Full Text]  
• Strickberger, S. A., Benson, D. W., Biaggioni, I., Callans, D. J., Cohen, M. I., Ellenbogen, K. A., Epstein, A. E., Friedman, P., Goldberger, J., Heidenreich, P. A., Klein, G. J., Knight, B. P., Morillo, C. A., Myerburg, R. J., Sila, C. A. (2006). AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. J Am Coll Cardiol 47: 473-484 [Full Text]  
• Strickberger, S. A., Benson, D. W., Biaggioni, I., Callans, D. J., Cohen, M. I., Ellenbogen, K. A., Epstein, A. E., Friedman, P., Goldberger, J., Heidenreich, P. A., Klein, G. J., Knight, B. P., Morillo, C. A., Myerburg, R. J., Sila, C. A. (2006). AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society. Circulation 113: 316-327 [Full Text]  
• Nugent, A. W., Daubeney, P. E.F., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C.W., Weintraub, R. G., for the National Australian Childhood Cardiomyopat, (2005). Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study. Circulation 112: 1332-1338 [Abstract] [Full Text]  
• Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., Maron, B. J. (2005). Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 1251-1258 [Abstract] [Full Text]  
• Dimitrow, P P, Dubiel, J S (2005). Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Heart 91: 93-94 [Full Text]  
• Katritsis, D. G, Camm, A.J. (2004). Nonsustained ventricular tachycardia: where do we stand?. Eur Heart J 25: 1093-1099 [Abstract] [Full Text]  
• Frenneaux, M. P (2004). Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90: 570-575 [Full Text]  
• Antezano, E. S., Hong, M. (2003). Sudden Cardiac Death. J Intensive Care Med 18: 313-329 [Abstract]  
• Hess, O. M. (2003). Risk stratification in hypertrophic cardiomyopathy: Fact or fiction?. J Am Coll Cardiol 42: 880-881 [Full Text]  
• Wren, C. (2002). Sudden death in children and adolescents. Heart 88: 426-431 [Full Text]  
• McKenna, W. J., Mogensen, J., Elliott, P. M. (2002). Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 39: 2049-2051 [Full Text]  

eLetters:

Read all eLetters

Hypertrophic cardiomyopathy: screening and management in childhood

Ingegerd Östman-Smith

Online, 6 Mar 2002 [Full text]